Law360, New York (September 27, 2012, 8:41 PM ET) -- A Washington federal judge ruled Thursday that many of the documents the Federal Trade Commission had sought from Boehringer Ingelheim Pharmaceuticals Inc. about its patent settlements with Barr Pharmaceuticals Inc. were privileged but ordered the drugmaker to quickly turn over the rest.
U.S. Magistrate Judge John M. Facciola found that Boehringer's financial analyses of a co-promotion agreement it reached with Barr for one of its drugs were an integral part of the patent litigation, requested by the company's attorneys to help evaluate settlement offers. This made...
Boehringer Can Keep Many Docs On Barr Deal Away From FTC
To view the full article, take a free trial now.
